| |
| |
|
| Insider
Information: |
Orbimed Capital Gp Vi Llc |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
17 |
|
| Direct
Shares |
5,826,224 |
|
|
Indirect Shares
|
46,949,846 |
|
|
| Direct
Value |
$193,255,850 |
|
|
|
Indirect Value
|
$504,861,587 |
|
|
| Total
Shares |
52,776,070 |
|
|
| Total
Value |
$698,117,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -513.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synlogic Inc |
SYBX |
Director |
|
0 |
2021-04-20 |
3,696,662 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
10% Owner |
2018-01-12 |
0 |
2018-02-08 |
3,447,840 |
Premium* |
|
|
Adicet Bio, Inc |
ACET |
Director, 10% Owner |
2018-01-30 |
0 |
2018-01-30 |
4,830,387 |
Premium* |
|
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
2018-07-23 |
0 |
2018-07-23 |
417,921 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Director, 10% Owner |
2019-01-18 |
0 |
2020-12-28 |
3,070,955 |
Premium* |
|
|
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
Director, 10% Owner |
2019-05-13 |
0 |
2019-05-13 |
2,711,013 |
Premium* |
|
|
Prevail Therapeutics Inc. |
PRVL |
Director, 10% Owner |
|
0 |
2021-01-22 |
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
10% Owner |
2019-09-17 |
0 |
2022-09-12 |
5,599,842 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
10% Owner |
|
0 |
2021-01-07 |
7,520,600 |
Premium* |
|
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2020-04-24 |
0 |
2021-03-30 |
2,212,571 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
|
0 |
2020-09-24 |
206,912 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
10% Owner |
2020-09-25 |
0 |
2020-09-29 |
4,163,347 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director, 10% Owner |
|
0 |
2020-12-03 |
538,646 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
2021-02-05 |
5,826,224 |
|
0 |
Premium* |
|
|
Neuropace Inc |
NPCE |
10% Owner |
2021-04-21 |
0 |
2024-05-03 |
3,406,335 |
Premium* |
|
|
Turnstone Biologics Corp. |
TSBX |
Director, 10% Owner |
2023-07-20 |
0 |
2023-07-20 |
3,099,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2023-10-03 |
4 |
S |
$9.02 |
$6,314 |
I/I |
(700) |
4,003,967 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-11 |
4 |
S |
$14.49 |
$6,692,917 |
I/I |
(461,899) |
3,542,068 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-12 |
4 |
S |
$14.42 |
$333,116 |
I/I |
(23,101) |
3,518,967 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-16 |
4 |
S |
$14.01 |
$197,107 |
I/I |
(14,069) |
3,504,898 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-17 |
4 |
S |
$14.15 |
$4,245 |
I/I |
(300) |
3,504,598 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-18 |
4 |
S |
$14.06 |
$36,879 |
I/I |
(2,623) |
3,501,975 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-19 |
4 |
S |
$14.02 |
$255,907 |
I/I |
(18,253) |
3,483,722 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-22 |
4 |
S |
$14.05 |
$345,756 |
I/I |
(24,609) |
3,459,113 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
S |
$14.29 |
$311,393 |
I/I |
(21,791) |
3,437,322 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-24 |
4 |
S |
$14.06 |
$25,041 |
I/I |
(1,781) |
3,435,541 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-05-01 |
4 |
S |
$14.02 |
$219,974 |
I/I |
(15,690) |
3,419,851 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-05-02 |
4 |
S |
$14.01 |
$123,876 |
I/I |
(8,842) |
3,411,009 |
0 |
% |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-05-03 |
4 |
S |
$14.03 |
$65,576 |
I/I |
(4,674) |
3,406,335 |
0 |
% |
|
| NXTC |
Nextcure, Inc. |
Director |
– • • |
2019-05-13 |
4 |
B |
$15.00 |
$5,250,000 |
I/I |
350,000 |
2,711,013 |
2.25 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • • |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,361,013 |
2,361,013 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • • |
2020-04-24 |
4 |
B |
$16.00 |
$4,500,000 |
I/I |
281,250 |
281,250 |
2.25 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • • |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,484,467 |
2,765,717 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-11 |
4 |
AS |
$33.04 |
$1,934,525 |
I/I |
(58,551) |
2,707,166 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-12 |
4 |
AS |
$30.29 |
$2,741,881 |
I/I |
(90,521) |
2,616,645 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-15 |
4 |
AS |
$29.14 |
$2,599,579 |
I/I |
(89,210) |
2,527,435 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-16 |
4 |
AS |
$27.72 |
$1,146,305 |
I/I |
(41,353) |
2,486,082 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-17 |
4 |
AS |
$28.43 |
$534,200 |
I/I |
(18,790) |
2,467,292 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-18 |
4 |
AS |
$28.03 |
$169,834 |
I/I |
(6,059) |
2,461,233 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-19 |
4 |
AS |
$26.47 |
$563,149 |
I/I |
(21,275) |
2,439,958 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-22 |
4 |
AS |
$26.47 |
$203,104 |
I/I |
(7,673) |
2,432,285 |
0 |
- |
|
84 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
